![]() |
|
|
Vol. 289, Issue 2, 682-687, May 1999
Johns Hopkins Asthma and Allergy Center, Baltimore, Maryland
| |
Abstract |
|---|
|
|
|---|
In vitro electrophysiological techniques were used to examine the
effect of bradykinin on guinea pig trachea and bronchus afferent nerve
endings arising from the nodose or jugular ganglia. The data reveal
that bradykinin activates nerve terminals of jugular C and A
fibers.
Although the fibers were too few in number to study rigorously,
bradykinin also stimulated nodose C fibers innervating the trachea and
bronchus. In contrast, A
fibers arising from the nodose ganglion
were unresponsive to bradykinin challenge. The responses in both
jugular C and A
fiber types were blocked by a selective bradykinin
B2 receptor antagonist and were not dependent on the
efferent release of sensory neuropeptides. These data indicate that the
sensitivity of guinea pig airway afferent fibers to bradykinin is
dependent more on the ganglionic origin of the cell body than on the
conduction velocity of its axon.
| |
Introduction |
|---|
|
|
|---|
Bradykinin, a
metabolite of the kallikrein-kinin system, has multiple effects on
airway function in guinea pigs, including bronchoconstriction,
vasodilatation, plasma extravasation, mucus secretion, and cough. These
effects are thought to be due, at least in part, to the activation of
sensory nerves leading to both axonal and central reflex activity
(Saria et al., 1983
; Ichinose et al., 1990
; Ichinose and Barnes, 1990
;
Barnes, 1992
; Inoue et al., 1992
; Miura et al., 1992
; Geppetti,
1993
). The afferent innervation in the guinea pig airways is
predominantly vagal in origin. The vagal afferent nerve terminals
subserving the trachea and bronchus arise from cell bodies located in
either the nodose or jugular ganglia (Kummer et al., 1992
; Riccio et
al., 1996
). The axons arising from these ganglia conduct action
potentials mainly in the C (<1.5 m/s) or A
(3-20 m/s) range
(Riccio et al., 1996
).
The nature of the specific afferent nerve populations in the guinea pig
airways stimulated by bradykinin is not yet fully understood. The
axonal reflexes in the airways can be inhibited by tachykinin receptor
antagonists and thus are due to stimulation of the
tachykinin-containing afferent nerve terminals (Lundberg, 1995
). In
guinea pig airways, tachykinin-containing afferent nerve terminals
characteristically have unmyelinated (C fiber) axons, with cell bodies
located in the jugular ganglion (Riccio et al., 1996
). Fox et al.
(1993)
demonstrated that bradykinin directly stimulates C fiber
afferents in vitro in guinea pig airways. Bergren (1997)
noted that
bradykinin can also lead to activation of A
fibers in the guinea pig
airways, but this effect was attributed to secondary effects on lung
mechanics. Recently, we found that perhaps more important than axonal
conduction velocity, the ganglionic location of the cell body is a
major determinant in the physiology of vagal afferent fibers in the
airways (Riccio et al., 1996
; Pedersen et al., 1998
). For example,
nodose nerve endings in the airways are exquisitely sensitive to
mechanical stimulation, whereas the nerve endings derived from jugular
neurons are less sensitive to mechanical stimuli but more sensitive to
hypertonic saline and irritants such as capsaicin. This is the case
regardless of whether the axon conducts action potentials in the C or
A
range.
In the present study, our aim was to characterize the subset of afferent nerves that are directly stimulated by bradykinin. The characterization was based both on their axonal conduction velocities and on the ganglionic location of their cell body. We found that bradykinin stimulates virtually all fibers arising from the jugular ganglia, regardless of conduction velocity, whereas only C fibers from the nodose ganglia are stimulated.
| |
Materials and Methods |
|---|
|
|
|---|
Tissue Preparation.
Guinea pigs (Dunkin-Hartley; male,
100-300 g) were sacrificed by CO2 asphyxiation
and exsanguinated. The trachea, mainstem bronchi, along with the right
vagus nerve, and superior and recurrent laryngeal nerves with attached
nodose and jugular ganglia were isolated and placed in a Plexiglas
chamber and superfused with Krebs' physiological buffer solution
maintained at 37°C (buffer composition: 118 mM NaCl, 5.4 mM KCl, 1.0 mM NaH2PO4, 1.2 mM
MgSO4, 1.9 mM CaCl2, 25 mM
NaHCO3, 11.1 mM dextrose, gassed with a mixture of 95% oxygen and 5% carbon dioxide) at a flow rate of 6 to 8 ml/min.
The larynx, trachea, and bronchus were opened longitudinally on their
ventral surface and pinned to the Sylgard lining of the Plexiglas
chamber. The jugular and nodose ganglia, along with attached nerves,
were gently pulled through a hole leading to a separate, adjacent
compartment in the same chamber where extracellular recordings were
performed. Both chambers were perfused separately with buffer solution.
The detailed procedure for in vitro electrophysiological recordings of
stimulated sensory nerve terminals in guinea pig airways has been
described previously (Riccio et al., 1996
).
Recording of Action Potentials.
Extracellular recordings
were made by positioning an alumino-silicate glass microelectrode
filled with 3 M NaCl solution (electrode resistance,
2 M
) near
neuronal cell bodies located in either the nodose or jugular ganglion.
The recorded signal was amplified (A-M Systems, Everett, WA) and
displayed online on an oscilloscope (TDS 320; Tektronix, Wilsonville,
OR). Data were stored on magnetic tape using a digital/audio tape
recorder (DTC 59ES; sampling frequency, 22 kHz; Dagan Corporation,
Minneapolis, MN). The recorded action potential discharge was digitized
and analyzed off line using a customized spike discrimination and
counting software program (D. M. MacGlashan, PHOCIS,
Baltimore, MD). This program is designed to both quantify spike
frequency and discriminate waveforms. The fiber of interest was
identified after mechanical stimulation of the receptive field. For the
off-line analysis, discrimination "windows" were placed such that
only waves that corresponded with the predetermined amplitude and width
were accepted for analysis. In most cases, only a single unit was
recorded by the recording electrode, rendering window discrimination unnecessary.
Determination of Fiber Activity and Detection of Afferent Nerve Terminals. Single-fiber activity in the airways was detected by stimulating the recurrent laryngeal nerve with a suction-type electrode while the recording electrode was carefully manipulated in the jugular or nodose ganglion until single unit activity was recorded. The receptive field for the recorded fiber activity was then located using gentle mechanical probing of the surface of the trachea and right main bronchus with a blunt plastic rod (o.d. 2 mm). The exact locus of the receptive field was determined when a reproducible burst of action potentials was elicited after gentle mechanical touching of a specific area on the airway luminal surface. Only mechanically sensitive neurons were studied. The nerve fibers studied had little or no activity at rest. When the "spontaneous activity" exceeded 1 action potential/s, the fiber was not studied further.
Characterization of Airway Afferent Fibers.
The conduction
velocity of the fibers studied were determined by electrically
stimulating the receptive field with a concentric electrode (0.5-mm tip
diameter) and monitoring the time (ms) elapsed between appearance of
the shock artifact and action potential. This value was divided by the
distance (mm) between the receptive field and the recording electrode.
Fibers were classified as C fibers if they conducted potentials at
<1.3 m/s and as A
fibers if they conducted action potentials at
>2.0 m/s. Fibers that conducted action potentials in the intermediary
range (1.3-2.0 m/s) were excluded from this study because they could
fall into either category.
Chemical Stimuli. The chemosensitivity of airway afferent nerve terminals to bradykinin and capsaicin was determined by perfusing these drugs directly onto the receptive field at a rate of 6 ml/min for 3 min. The response of afferent fibers to bradykinin was recorded for 5 min. No more than three increasing concentrations of bradykinin were tested on any one tissue. In some experiments, a single concentration of capsaicin was applied at the end of the study. A washout period of at least 10 min was used between increasing bradykinin concentrations. The perfused drugs were removed with a separate suction outlet positioned 5 mm from the receptive field to avoid stimulation of surrounding receptive fields.
For bradykinin receptor antagonist and cyclooxygenase inhibitor studies, the tissue was pretreated with antagonist or inhibitor for at least 10 min before bradykinin or capsaicin challenge. For neurokinin receptor antagonist studies, the tissue was pretreated for 15 min with a combination of the NK-1, NK-2, and NK-3 receptor antagonists SR-140333, SR-48968, and SR-142801 (1 µM), respectively. A control response to bradykinin (1 µM) was obtained before the addition of the antagonist cocktail. In these studies, bradykinin was applied topically onto the receptive field as a bolus (500 µl over ~5 s). Intracellular recording experiments were performed as described previously (Undem and Weinreich, 1993
resistance) were connected by an electrode holder (Axon Instruments, Burlingame, CA) to an electrometer (Axoclamp 2A; Axon
Instruments). Neurons were characterized as having C-type axons as
described. After the establishment of a stable resting membrane
potential (usually 2-5 min after impalement), bath-applied (2-3 min,
16-24 ml) bradykinin-induced changes in membrane potential were
monitored and compared with the prebradykinin resting potential. Responses evoked by bradykinin (1 nM to 1 µM) were monitored until a
steady-state response was observed (2-3 min), with a 5- to 10-min washout period between applications. Complete concentration responses for bradykinin were not performed on a single neuron; consequently, the
concentration responses were constructed by single or double exposure,
beginning with a low concentration followed by washout and, if
possible, a higher concentration.
Isometric tension of tracheal smooth muscle was simultaneously
monitored with extracellular recordings of A
fiber activation by
bradykinin. Two incisions (
2 mm each), two tracheal rings apart,
were made on the right side of the trachea just caudal to the origin of
the recurrent laryngeal nerve from the vagus nerve. The resulting
"flap" of trachea was secured with suture to a Grass FT03C
isometric force transducer under a resting tension of 1g.
The opposing side of the trachea was pinned firmly to the Sylgard of
the chamber. Changes in smooth muscle tension relayed to the transducer
were recorded on a chart recorder (TA240S; Gould, Valley View, OH).
Attempts were made to identify a receptive field of a jugular A
fiber within a 10- to 15-mm radius of the tracheal smooth muscle under
study for tension studies.
Chemicals.
Bradykinin was obtained from Peninsula
Laboratories (Belmont, CA). A stock solution (0.1 mM) was prepared in
distilled water and stored in aliquots at
20°C. Further dilutions
were made in Krebs' buffer solution on the day of use. Hoe 140 (D-Arg-[Hyp3,Thi5,D-Tic7,Oic8]bradykinin)
was a generous gift from Dr. K. Wirth (Hoechst AG, Frankfurt, Germany).
Methacholine and indomethacin were purchased from Sigma Chemical Co.
(St. Louis, MO). A stock solution of indomethacin (10 mM) was prepared
in 100% ethanol and diluted in Krebs' buffer solution on the day of
use. Methacholine was prepared as a stock solution of 0.1 M in
distilled water and further diluted in Krebs' buffer solution.
SR-140333, SR-48968, and SR-142801 were generous gifts from Zeneca
Pharmaceuticals Group (Wilmington, DE). SR-140333 was prepared as a
stock solution (50 mM) in dimethyl sulfoxide. SR-48968 and SR-142801
were prepared as a stock solution (10 mM) in distilled water. All three
antagonists were stored at
20°C until the day of use, when required
dilutions were made in Krebs' buffer solution.
Data Analysis. All data are expressed as the arithmetic mean ± S.E.M. For extracellular recording experiments, the responses of afferent neurons to chemical stimulation are presented graphically as the total number of action potentials recorded. The peak frequency of action potentials represents the highest number of action potentials discharged in a 1-s time period. For intracellular recording experiments, the responses of C cell somata to bradykinin are presented graphically as the change in membrane potential (mV). All data were statistically analyzed using one-way ANOVA followed by Student's nonpaired t test. Differences with a value of p < .05 were considered significant.
| |
Results |
|---|
|
|
|---|
Electrophysiological Investigations: General Characteristics of
Airway Afferent Nerves.
Afferent nerves with terminal projections
in the trachea and right bronchus from 51 guinea pigs were studied. Of
these terminals, 33 originated from cell bodies located in the jugular
ganglion, and 18 originated from cell bodies located in the nodose
ganglion. These nerve endings had axons subclassified as C and A
fibers based on their conduction velocity. Approximately half of the axons from the jugular ganglion neurons (14 of 33) conducted action potentials in the C fiber range (mean conduction velocity, 0.75 ± 0.06 m/s), whereas the remainder of the fibers conducted in the A
range (mean conduction velocity, 5.12 ± 0.65 m/s). The majority
of airway afferent nerve fibers arising from the nodose ganglia (14 of
18 fibers) were A
fibers (mean conduction velocity, 5.21 ± 0.72 m/s); only four fibers conducted action potentials in the C fiber
range (mean conduction velocity, 1.11 ± 0.09 m/s). This is
consistent with previous anatomic and electrophysiological studies that
have demonstrated that relatively few cell bodies in the nodose
ganglion project C-type axons to the guinea pig trachea and bronchus
(Riccio et al., 1996
). Axons that conducted action potentials in the
intermediary range (1.3-2.0 m/s) were excluded from this study
(n = 4). As the receptive fields of all fibers studied
were located by gentle mechanical probing, only mechanically sensitive
fibers were studied. A small number of mechanically insensitive
receptive fields (n = 3) were identified using
electrical search techniques (see Riccio et al., 1996
), these fibers
were not studied further. The respective mechanical thresholds were
2.3 ± 0.4 mN (n = 14) and 1.2 ± 0.4 mN
(n = 13) for activating A
and C fibers from the
jugular ganglion and 0.2 ± 0.01 mN (n = 6) for
activating nodose ganglion A
fibers.
Responses to Bradykinin.
The application of 1 µM bradykinin
directly over the receptive fields of afferent fibers in the guinea pig
trachea and bronchus resulted in action potential discharge from
jugular A
- and C-conducting neurons. By contrast, A
fiber
terminals in the trachea-bronchus that originated in the nodose ganglia
were unresponsive to bradykinin (Fig. 1).
A similar profile of responsiveness was observed when capsaicin (1 µM) was applied to the receptive fields. Thus, capsaicin stimulated
jugular fiber terminals regardless of conduction velocity, whereas
nodose A
fiber terminals were unresponsive to this stimulus (Fig.
1). All four nodose C fiber terminals responded to bradykinin and
capsaicin (1 µM; data not shown); however, due to the scarcity of
nodose C fiber terminals in the guinea pig trachea and bronchus, further pharmacological manipulations were not performed on these receptive fields. Representative traces of the responses of jugular C
and A
fibers and nodose A
fibers to bradykinin are shown in Fig.
2A. This response typically commenced
within 30 s of bradykinin perfusion and often continued but never
for a longer total response time than 5 min. Often, the response to
bradykinin, in both C and A
fiber terminals, appeared as bursts of
action potentials lasting for 20 to 30 s (see jugular C fiber
response in Fig. 2A). However, in some preparations, a continuous
response to drug application was observed (see jugular A
fiber
response in Fig. 2A). The significance of the bursting response is
unclear and was observed in both C- and A
-conducting neurons.
|
|
fibers were similar, with the threshold concentrations typically in the
range of 10 nM. With respect to the peak frequency of action potential discharge, as well as the total number of action potentials evoked, bradykinin was about two times more effective in stimulating C fiber
terminals than A
fiber terminals (Fig. 2B).
It is conceivable that the bradykinin concentration in the superfusion
solution may not adequately reflect that found in the region of the
nerve endings, possibly due to access-diffusion barriers or the
prevalence of metabolizing enzymes in the guinea pig airway (Dendorfer
et al., 1997
|
fiber types (Fig.
4). In separate studies, we observed reproducible responses to as many as three applications of bradykinin (0.1 µM) in the absence of antagonist with no evidence of
tachyphylaxis (data not shown). Hoe 140 did not significantly alter
capsaicin-induced excitation of jugular fibers. The selective
B1 receptor agonist, des-Arg10-kallidin (1 µM), did not excite
jugular C or A
fibers (C fibers, n = 3; A
fibers,
n = 4).
|
fibers by bradykinin (0.01-1 µM) is not
secondary to changes in airway smooth muscle tension. No change in
muscle tension was recorded during the activation of jugular C
(n = 1) and A
(n = 2) fibers. The
viability of the smooth muscle to contractile agents was confirmed by
the topical application (250 µl) of methacholine (100 µM) over the
receptive field of the afferent fiber under study. Methacholine caused
a 0.7 ± 0.03 g increase in muscle tension (n = 3).
Pretreatment of the tissue with a combination of NK-1, NK-2, and NK-3
receptor antagonist, SR-140333, SR-48968, and SR-142801 (1 µM),
respectively, did not alter the response of A
fibers to bradykinin.
In two experiments, bradykinin (1 µM) caused action potential
discharge from jugular A
fibers with a peak frequency of 8 and 20 peaks/s in the absence of the neurokinin receptor antagonists and 7 and
24 peaks/s, respectively, in the presence of antagonists. Likewise,
indomethacin (3 µM) had no effect on the bradykinin (0.1 µM)-induced action potential discharge from jugular A
- or
C-conducting fibers (mean peak firing frequency in A
fibers:
bradykinin alone, 3 ± 1 peaks/s; bradykinin plus indomethacin,
3.3 ± 2 peaks/s, n = 3; in C fibers: bradykinin alone, 4 ± 1 peaks/s; bradykinin plus indomethacin, 3 ± 2 peaks/s, n = 3).
| |
Discussion |
|---|
|
|
|---|
In the present study, we demonstrate that the chemical activation
of guinea pig airway afferent nerve endings by bradykinin and capsaicin
is dependent primarily on the location of their cell bodies. We
observed that both C and A
fiber terminals that originate in the
jugular ganglion are activated by bradykinin. A similar response was
observed for capsaicin, an agent classically used as a pharmacological
tool for selective C fiber stimulation. In contrast, the application of
bradykinin or capsaicin on the receptive fields of airway nodose A
fibers failed to cause action potential generation. Consistent with our
previous studies, relatively few C fibers with receptive fields in the
guinea pig trachea and bronchus originate in the nodose ganglion
(Riccio et al., 1996
; Pedersen et al., 1998
); hence, we are unable to
make a definitive statement on the chemosensitivity of nodose
C-conducting fibers. However, it is worth noting that of the few nodose
C-fiber receptive fields studied (n = 4), each
responded to bradykinin and capsaicin in the same manner as jugular C fibers.
Bradykinin has been previously reported to stimulate receptive fields
of both C and A
fibers in guinea pig lung (Bergren, 1997
). The
stimulation of A
fibers, however, was inhibited by a
-adrenoceptor agonist and thus was attributed to secondary effects
on lung mechanics. This would be consistent with the observations by
Fox et al. (1993)
that in the guinea pig isolated tracheal preparation,
bradykinin-stimulated vagal C fibers, but not A
fibers, were noted.
The present findings, however, indicate that a subpopulation of A
fibers do indeed respond to direct application of bradykinin, as long
as their cell bodies are located in the jugular ganglion. The reason
for the discrepancy between the results presented here and those
reported by Fox et al. (1993)
is not known. It is possible that the
difference in experimental design accounts for the differing results.
When recording single unit activity from nerve fibers along the trunk
of the vagus nerve (i.e., the method used by Fox et al.), it is not
possible to consider the ganglionic source of the fiber. It is
conceivable, therefore, that in the study by Fox et al., the A
fibers (n = 7) that were reported not to respond to
bradykinin were derived from cell bodies located in the nodose ganglion.
It is unlikely that the stimulation of jugular A
fiber terminals is
an indirect effect. That bradykinin stimulated A
fibers in the
isolated tissue rules out any effects secondary to lung mechanics or
vascular events. We evaluated the effect of bradykinin on isometric
tension of the smooth muscle in guinea pig trachea during concomitant
electrophysiological recordings of jugular A
fiber excitation.
Bradykinin had negligible effects on smooth muscle tone at the
concentrations that effectively activated jugular nerve fibers.
Bradykinin is known to increase the excitability of guinea pig vagal
sensory neurons by inhibiting a slow calcium-dependent hyperpolarizing
current (Undem and Weinreich, 1993
). This effect is secondary to the
production of prostacyclin (Weinreich et al., 1995
). In the present
study, however, we noted that the stimulation of jugular A
fiber
terminals by bradykinin was not dependent on the production of
prostaglandins because pretreatment of the tissue with indomethacin did
not inhibit the response in these fibers. A similar lack of involvement
of prostaglandins in the C fiber-mediated responses to bradykinin was
observed in this and previous studies (Fox et al., 1993
). We also
addressed the hypothesis that bradykinin selectively stimulates C
fibers causing the release of sensory neuropeptides, which in turn
stimulates jugular A
fibers. However, the bradykinin-induced
activation of jugular A
fibers was unaltered in the presence of
neurokinin receptor antagonists. Furthermore, neither Substance P nor
calcitonin gene-related peptide stimulates guinea pig airway afferent
fibers in vitro (data not shown). Taken together, these data suggest that the response to bradykinin observed in jugular A
fibers is
mediated by the same direct mechanism as that for jugular C fibers.
Consistent with the observation of Fox et al. (1993)
, the results
support the hypothesis that bradykinin-induced stimulation of airway C
fibers is secondary to activation of B2 type
receptors. This also holds true for stimulation of jugular A
fibers
in the guinea pig airway. Thus, the selective B2
receptor antagonist Hoe 140 was effective in inhibiting the response of
both jugular C and A
fibers to bradykinin. Challenge with a
B1 receptor agonist did not lead to action
potential discharge in any afferent fiber type in the guinea pig trachea.
Concentrations of bradykinin of more than 1 nM were required to stimulate the jugular nerve endings in this experimental design. To establish whether the effectiveness of bradykinin in this preparation was reduced by epithelium-derived peptidases or by access barriers, we studied the effect of bradykinin applied directly onto the somata of jugular neurons. Using intracellular recording techniques, we observed that the effective dose range of bradykinin to cause membrane depolarization of jugular C cell somata was similar to that required to excite the nerve terminals in the trachea-bronchus of guinea pigs. These results suggest that the access of bradykinin at afferent terminals in the trachea-bronchus was not hampered by barriers or epithelium-derived peptidases.
In conclusion, these data demonstrate that in the guinea pig trachea,
bradykinin activates both sensory C fibers and A
fibers. The
stimulation of A
fibers, however, is strictly dependent on the
location of the cell body. The jugular A
fibers are responsive to
bradykinin, whereas A
fibers arising from nodose neurons are not.
Neurons in the jugular ganglion are thought to be derived from
different embryological structures than those in the nodose ganglia
(Altman and Bayer, 1982
), and it is likely that they are linked to
different reflex physiology. Knowledge of the nature of the primary
afferent nerves stimulated by bradykinin is essential to the eventual
understanding of the mechanism underlying bradykinin-induced neuronal
reflexes in the airways. The present findings, considered together with
previous observations, indicate that bradykinin stimulates the same
subset of primary sensory fibers in the guinea pig trachea that are
activated by capsaicin and hypertonic saline (Riccio et al., 1996
;
Pedersen et al., 1998
).
| |
Footnotes |
|---|
Accepted for publication December 17, 1998.
Received for publication August 31, 1998.
1 This work was supported by grants from the National Institutes of Health.
Send reprint requests to: Bradley J. Undem, Ph.D., Johns Hopkins Asthma and Allergy Center, 5501 Hopkins Bayview Circle, Baltimore, MD 21224.
| |
Abbreviation |
|---|
Hoe 140, D-Arg-[Hyp3,Thi5,D-Tic7,Oic8]bradykinin.
| |
References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
G. Zhang, R.-L. Lin, M. E. Wiggers, and L.-Y. Lee Sensitizing effects of chronic exposure and acute inhalation of ovalbumin aerosol on pulmonary C fibers in rats J Appl Physiol, July 1, 2008; 105(1): 128 - 138. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. K. M. Lennerz, C. Dentsch, N. Bernardini, T. Hummel, W. L. Neuhuber, and P. W. Reeh Electrophysiological characterization of vagal afferents relevant to mucosal nociception in the rat upper oesophagus J. Physiol., July 1, 2007; 582(1): 229 - 242. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. R. Bergren Prostaglandin involvement in lung C-fiber activation by substance P in guinea pigs J Appl Physiol, June 1, 2006; 100(6): 1918 - 1927. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. B. Mazzone, N. Mori, and B. J. Canning Synergistic interactions between airway afferent nerve subtypes regulating the cough reflex in guinea-pigs J. Physiol., December 1, 2005; 569(2): 559 - 573. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-G. Lee, D. W MacGlashan Jr, and B. J Undem Role of chloride channels in bradykinin-induced guinea pig airway vagal C-fibre activation J. Physiol., July 1, 2005; 566(1): 205 - 212. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J. Oh and D. Weinreich Bradykinin decreases K+ and increases Cl- conductances in vagal afferent neurones of the guinea pig J. Physiol., July 15, 2004; 558(2): 513 - 526. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. J. Canning, S. B. Mazzone, S. N. Meeker, N. Mori, S. M. Reynolds, and B. J. Undem Identification of the tracheal and laryngeal afferent neurones mediating cough in anaesthetized guinea-pigs J. Physiol., June 1, 2004; 557(2): 543 - 558. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. J. Undem, B. Chuaychoo, M.-G. Lee, D. Weinreich, A. C. Myers, and M. Kollarik Subtypes of vagal afferent C-fibres in guinea-pig lungs J. Physiol., May 1, 2004; 556(3): 905 - 917. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. J. Undem, E. J. Oh, E. Lancaster, and D. Weinreich Effect of Extracellular Calcium on Excitability of Guinea Pig Airway Vagal Afferent Nerves J Neurophysiol, March 1, 2003; 89(3): 1196 - 1204. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Carr, M. Kollarik, S. N. Meeker, and B. J. Undem A Role for TRPV1 in Bradykinin-Induced Excitation of Vagal Airway Afferent Nerve Terminals J. Pharmacol. Exp. Ther., March 1, 2003; 304(3): 1275 - 1279. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Mutoh and H. Tsubone Hypersensitivity of Laryngeal C-Fibers Induced by Volatile Anesthetics in Young Guinea Pigs Am. J. Respir. Crit. Care Med., February 15, 2003; 167(4): 557 - 562. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. B. Mazzone and B. J. Canning Synergistic interactions between airway afferent nerve subtypes mediating reflex bronchospasm in guinea pigs Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2002; 283(1): R86 - R98. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. C. Myers, R. Kajekar, and B. J. Undem Allergic inflammation-induced neuropeptide production in rapidly adapting afferent nerves in guinea pig airways Am J Physiol Lung Cell Mol Physiol, April 1, 2002; 282(4): L775 - L781. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. J. Canning, S. M. Reynolds, and S. B. Mazzone Multiple mechanisms of reflex bronchospasm in guinea pigs J Appl Physiol, December 1, 2001; 91(6): 2642 - 2653. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. CARR, N. M. SCHECHTER, and B. J. UNDEM Trypsin-induced, Neurokinin-mediated Contraction of Guinea Pig Bronchus Am. J. Respir. Crit. Care Med., November 1, 2000; 162(5): 1662 - 1667. [Abstract] [Full Text] |
||||
![]() |
D. D. HUNTER, A. C. MYERS, and B. J. UNDEM Nerve Growth Factor-Induced Phenotypic Switch in Guinea Pig Airway Sensory Neurons Am. J. Respir. Crit. Care Med., June 1, 2000; 161(6): 1985 - 1990. [Abstract] [Full Text] |
||||
![]() |
R. Kajekar and A. C. Myers Effect of bradykinin on membrane properties of guinea pig bronchial parasympathetic ganglion neurons Am J Physiol Lung Cell Mol Physiol, March 1, 2000; 278(3): L485 - L491. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||